Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes. [Diabetes : Treatment Satisfaction]
Diabetic Medicine, 18 (8), 619-625. View article here.
Validation of the HIV Treatment Satisfaction Questionnaire (HIVTSQ). [HIV : Treatment Satisfaction]
Quality of Life Research, 10, 517-531. View article here.
The ADKnowl: identifying knowledge deficits in diabetes care. [Diabetes : Knowledge]
Diabetic Medicine, 18 (8) 626-639. View article here.
The Dose Adjustment For Normal Eating (DAFNE) Trial: What makes people with Type 1 diabetes agree/decline to participate? [Diabetes : Quality of Life]
Diabetic Medicine, 18(2): 129.
DAFNE (Dose Adjustment For Normal Eating): Methodology and Quality Assurance for Exploratory trial. [Diabetes : Quality of Life]
Diabetic Medicine, 18(2): 130.
Experiences of macular disease and the UK health care system. [Macular Disease]
Proceedings of the British Psychological Society, 9 (1), 71.
Risk and Prevention of type 2 diabetes: offspring’s views. [Diabetes]
British Journal of General Practice, 51, 194-199.
Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. [Macular Disease : Well Being]
Three months’ withdrawal of growth hormone (GH) therapy from GH-deficient adults does not affect cognitive functioning. [Hormone Deficiency]
Endocrine Abstracts, 1, P110.
Psychological effects of withdrawal of growth hormone (GH) therapy from GH-deficient adults. [Hormone Deficiency]
Endocrine Abstracts, 1, P111. View article here.
